1. Stauder R, Valent P, Theurl I. Anemia at older age: etiologies, clinical implications, and management. Blood. 2018;131:505-514.
2. Lefebvre P, Duh MS, Buteau S, Bookhart B, Mody SH. Medical costs of untreated anemia in elderly patients with pre-dialysis chronic kidney disease. J Am Soc Nerphrol. 2006;17(12):3497-3502.
3. Centers for Disease Control and Prevention. The State of Aging and Health in America 2013. Available at https://www.cdc.gov/aging/pdf/State-Aging-Health-in-America-2013.pdf. Last accessed January 8, 2024.
4. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299(17):2027-2036.
5. Centers for Disease Control and Prevention. QuickStats: The prevalence of anemia among adults aged >/=65 years, by sex and age group—National Health and Nutrition Examination Survey, 2013–2016. MMWR. 2018;67:1198.
6. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263-2268.
7. Bisbe E, Castillo J, Sáez M, Santiveri X, Ruíz A, Munoz M. Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective major orthopedic surgery. Transfusion Alter Transfusion Med. 2008;10(4):166-173.
8. Brown E, Bennett M. Survey of blood transfusion practice for palliative care patients in Yorkshire: implications for clinical care. J Palliat Med. 2007;10(4):919-922.
9. Artz AS, Fergusson D, Drinka PJ, et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc. 2004;52(3):423-427.
10. Steensma DP, Tefferi A. Anemia in the elderly: how should we define it, when does it matter, and what can be done? Mayo Clin Proc. 2007;82(8):958-966.
11. Artz AS. Anemia in Elderly Persons. Available at https://emedicine.medscape.com/article/1339998-overview. Last accessed January 8, 2024.
12. Lipschitz D. Medical and functional consequences of anemia in the elderly. J Am Geriatr Soc. 2003;51(3 Suppl):S10-S13.
13. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Geneva: World Health Organization; 2011.
14. Gado K, Khodier M, Virag A, et al. Anemia of geriatric patients. Physiol Internat. 2022;109:119-134.
15. Artz A. Racial impact of anemia and mortality in the elderly: abstract and commentary. Clinical Oncology Alert. 2007;23(7):53-54.
16. Aessopos A, Deftereos S, Farmakis D, et al. Cardiovascular adaptation to chronic anemia in the elderly: an echocardiographic study. Clin Invest Med. 2004;27(5):265-273.
17. National Hematologic Diseases Information Service. Anemia of Inflammation and Chronic Disease. Available at https://www.niddk.nih.gov/health-information/blood-diseases/anemia-inflammation-chronic-disease. Last accessed January 8, 2024.
18. Camaschella C, Weiss G. Anemia of Chronic Disease (Anemia of Chronic Inflammation). Available at https://www.uptodate.com/contents/anemia-of-chronic-disease-inflammation. Last accessed January 8, 2024.
19. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75(5):671-678.
20. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153(1):307-323.
21. National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin B12. Available at https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional. Last accessed January 8, 2024.
22. Coté GA, Howden CW. Potential adverse effects of proton pump inhibitors. Curr Gastroenterol Rep. 2008;10(3):208-214.
23. Cotter PE, O'Keeffe ST. Use of proton pump inhibitors is not associated with vitamin B12 deficiency and in older hospital patients: a case control study. Eur Geriatr Med. 2011;2(4):253-255.
24. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol. 2004;57(4):422-428.
25. Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008;9(3):162-167.
26. Nagalla S. Megaloblastic Anemia. Available at https://emedicine.medscape.com/article/204066-overview. Last accessed January 8, 2024.
27. Liu KW, Dai LK, Jean W. Metformin-related vitamin B12 deficiency. Age Ageing. 2006;35(2):200-201.
28. de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181.
29. Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM. Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med. 2006;166(18):1975-1979.
31. National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Fact Sheet: Folate. Available at https://ods.od.nih.gov/factsheets/Folate-HealthProfessional. Last accessed January 8, 2024.
32. National Cancer Institute. Myelodysplastic Syndromes Treatment (PDQ). Available at https://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq. Last accessed January 8, 2024.
33. Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37,485 individuals. Ann Intern Med. 2010;170(18):1622-1631.
34. Mason JB. Folate, cancer risk, and the Greek god, Proteus: a tale of two chameleons. Nutr Rev. 2009;67(4):206-212.
35. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113(5):825-828.
36. Valent P, Wimazal F, Sperr WR, Horny H-P. Diagnostic criteria and classification of myelodysplastic syndromes. In: Várkonyi J (ed). The Myelodysplastic Syndromes. New York, NY: Springer; 2011: 43-54.
37. Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults: part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician. 2004;70(5):869-876.
38. National Heart, Lung, and Blood Institute. Hemolytic Anemia. Available at https://www.nhlbi.nih.gov/health/anemia/hemolytic-anemia. Last accessed January 8, 2024.
39. National Heart, Lung, and Blood Institute. Sickle Cell Disease. Available at https://www.nhlbi.nih.gov/health/sickle-cell-disease. Last accessed January 8, 2024.
40. World Health Organization. Sickle Cell Anaemia: Report by the Secretariat. Available at https://apps.who.int/gb/archive/pdf_files/WHA59/A59_9-en.pdf. Last accessed January 8, 2024.
41. Maakaron JE. Sickle Cell Anemia. Available at https://emedicine.medscape.com/article/205926-overview. Last accessed January 8, 2024.
42. Centers for Disease Control and Prevention. Sickle Cell Disease (SCD): Data and Statistics. Available at https://www.cdc.gov/NCBDDD/sicklecell/data.html. Last accessed January 8, 2024.
43. National Heart, Lung and Blood Institute. Thalassemias. Available at https://www.nhlbi.nih.gov/health/thalassemia. Last accessed January 8, 2024.
45. National Heart, Lung and Blood Institute. Aplastic Anemia. Available at https://www.nhlbi.nih.gov/health/anemia/aplastic-anemia. Last accessed January 8, 2024.
46. National Institute of Diabetes and Digestive and Kidney Diseases. Aplastic Anemia and Myelodysplastic Syndromes. Available at https://www.niddk.nih.gov/health-information/blood-diseases/aplastic-anemia-myelodysplastic-syndromes. Last accessed January 8, 2024.
48. Taber's Online. Available at https://www.tabers.com/tabersonline. Last accessed January 8, 2024.
49. Colbert GB. Anemia of Chronic Disease and Renal Failure: Diagnosis. Available at https://emedicine.medscape.com/article/1389854-overview#aw2aab6b6. Last accessed January 8, 2024.
52. Makipour S, Kanapuru B, Ershler WB. Unexplained anemia in the elderly. Semin Hematol. 2008;45(4):250-254.
53. McKinney M, Arcasoy MO. Erythropoietin for oncology supportive care. Exp Cell Res. 2011;317(9):1246-1254.
54. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Available at https://www.kidney.org/sites/default/files/docs/anemiainckd.pdf. Last accessed January 8, 2024.
55. Lexicomp Online. Available at https://online.lexi.com. Last accessed January 8, 2024.
56. Agnihotri P, Telfer M, Butt Z, et al. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geratr Soc. 2007;55(10):1557-1565.
57. Paltiel O, Clarfield AM. Anemia in elderly people: risk marker or risk factor? CMAJ. 2009;181(3-4):129-130.
58. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118(10):1142-1147.
59. Brooks M. FDA Approves Injectafer for Iron Deficiency Anemia. Available at https://www.medscape.com/viewarticle/808800. Last accessed January 8, 2024.
60. Auerbach M, DeLoughery TG. Treatment of the Adult with Iron Deficiency Anemia. Available at https://www.uptodate.com/contents/treatment-of-anemia-due-to-iron-deficiency. Last accessed January 8, 2024.
61. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr. 2004;80(5):1123-1128.
62. Rosenberg M. Overview of the Management of Chronic Kidney Disease in Adults. Available at https://www.uptodate.com/contents/overview-of-the-management-of-chronic-kidney-disease-in-adults. Last accessed January 8, 2024.
63. Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002;20(19):4083-4107.
64. Goodnough LT, Schrier SL. Evaluation and management of anemia in the elderly. Am J Hematol. 2014;89:88-96.
65. 1zzakai NA, French B, Arnold AM, et al. Hemoglobin decline, function, and mortality in the elderly: The Cardiovascular Health Study. Am J Hematol. 2013;88:5-9.
67. Ferrucci L, Guralnik JM, Bandinelli S, et al. Unexplained anemia in older persons is characterized by low erythropoietin and low levels of pro-inflammatory markers. Br J Hematol. 2007;136(6):849-855.
68. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104:2263-2268.
1. Kidney Disease: Improving Global Outcomes. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Gut. 2021;70(11):2030-2051. Available at https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf. Last accessed January 11, 2024.
2. Snook J, Bhala N, Beales ILP, et al. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Ann Intern Med. 2013;159(11):770-779. Available at https://gut.bmj.com/content/70/11/2030.long. Last accessed January 11, 2024.
Mention of commercial products does not indicate endorsement.